Skip to main content
  • Saved

Commented on 's Post

Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy - PubMed

Fusarium rhinosinusitis post chimeric antigen receptor T-cell therapy - PubMed

Source :

https://pubmed.ncbi.nlm.nih.gov/33889489/

Chimeric antigen receptor T-cell (CAR-T) therapy is a novel treatment for various types of hematologic malignancy. We presented a case of refractory diffuse large B cell lymphoma patient who developed acute invasive fungal rhinosinusitis (AIFR) from Fusarium species after CAR-T therapy. Our p ...

  • 22 hours 39 min
    This report would benefit from a more detailed description of anc depression depth and duration as well as steroid dose/duration and prophylaxis of IFI